Functional Endoscopy in Neurogenic Dysphagia

Sponsor
University Hospital Muenster (Other)
Overall Status
Unknown status
CT.gov ID
NCT01995929
Collaborator
(none)
50
1
27
1.9

Study Details

Study Description

Brief Summary

The esophago-gastro-duodenoscopy is an endoscopic examination technique of the upper GI-tract which was founded by the German surgeon Johann Freiherr von Mikuliicz-Radecki at the end of 19th century. By this means, the luminal site of the esophagus, stomach and duodenum may be visualized after inserting a flexible endoscope through the mouth (transoral access). By the rapid technical development in the last years smaller flexible video endoscopes have been developed allowing also an alternative access to the upper GI-tract via the nose (transnasal access).

Patients with dysphagia are referred to physicians of different disciplines (gastroenterology, surgery, ear, nose, and throat (ENT) medicine, radiology, neurology) performing a variety of endoscopic and non-endoscopic techniques. Mostly, the endoscopic examination of the esophagus is done in sedated patients in left lateral examination. Typical findings during esophagoscopy might be tumors, strictures, achalasia or diverticula.

Patients suffering from neurogenic dysphagia often get caught in the trap: they find themselves somewhere in the space between gastroenterologist, neurologist, ENT-specialist and radiologist. This dilemma might be due to a lack of pathophysiological knowledge among many physicians and an inability to directly visualize the esophageal phase of deglutition. In sedated patients lying in left lateral position, endoscopists may receive a very limited impression of the function of the different phases of swallowing since this endoscopic access is a rather static one.

The focus of our observational study are patients with suspected neurogenic dysphagia. These patients shall be examined by transnasal endoscopy applying an ultrathin video endoscope with an outer diameter of 3.8 mm (BF-3C160, Olympus Europe). Patients are examined in sitting position while ingesting water and food of different consistencies (functional endoscopy). Diagnostic shall be completed and correlated by videofluoroscopy, high-resolution manometry and assessment of the clinical signs. Beside feasibility and safety as primary endpoints, secondary endpoints shall be the assessment of pathologic endoscopic findings in patients suffering from neurogenic dysphagia. The study is approved by the local Ethics Committee (AZ 2010-214-f-S).

Condition or Disease Intervention/Treatment Phase
  • Procedure: transnasal functional endoscopy

Detailed Description

The esophago-gastro-duodenoscopy is an endoscopic examination technique of the upper GI-tract which was founded by the German surgeon Johann Freiherr von Mikuliicz-Radecki at the end of 19th century. By this means, the luminal site of the esophagus, stomach and duodenum may be visualized after inserting a flexible endoscope through the mouth (transoral access). By the rapid technical development in the last years smaller flexible video endoscopes have been developed allowing also an alternative access to the upper GI-tract via the nose (transnasal access).

Patients with dysphagia are referred to physicians of different disciplines (gastroenterology, surgery, ear, nose, and throat (ENT) medicine, radiology, neurology) performing a variety of endoscopic and non-endoscopic techniques. Mostly, the endoscopic examination of the esophagus is done in sedated patients in left lateral examination. Typical findings during esophagoscopy might be tumors, strictures, achalasia or diverticula. In sedated patients lying in left lateral position, endoscopists may, therefore, receive a very limited impression of the actual function of the different phases of swallowing since this endoscopic approach is a rather static one.

Patients suffering from neurogenic dysphagia often get caught in the trap: they find themselves somewhere in the space between gastroenterologist, neurologist, ENT-specialist and radiologist. This dilemma might be due to a lack of pathophysiological knowledge among many physicians and an inability to directly visualize the esophageal phase of deglutition.

The focus of our observational study are patients with suspected neurogenic dysphagia. These patients shall be examined by transnasal endoscopy applying an ultrathin video endoscope with an outer diameter of 3.8 mm (BF-3C160, Olympus Europe). Patients are examined in sitting position while ingesting water and food of different consistencies (functional endoscopy). Diagnostic shall be completed and correlated by videofluoroscopy, high-resolution manometry and assessment of the clinical signs. Beside feasibility and safety as primary endpoints, secondary endpoints shall be the assessment of pathologic endoscopic findings in patients suffering from neurogenic dysphagia. The study is approved by the local Ethics Committee (AZ 2010-214-f-S).

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Transnasal Endoscopic Evaluation of Swallowing: Functional Esophagoscopy Using an Ultrathin Video Endoscope in Neurogenic Dysphagia
Study Start Date :
Sep 1, 2012
Anticipated Primary Completion Date :
Jul 1, 2014
Anticipated Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
neurogenic dysphagia

Patients suffering from neurogenic dysphagia due to several reasons (e.g. Parkinson´s disease).

Procedure: transnasal functional endoscopy
Other Names:
  • ultrathin video endoscope with an outer diameter of 3.8 mm (BF-3C160, Olympus Europe)
  • Outcome Measures

    Primary Outcome Measures

    1. Number of patients in which the procedure may be successfully performed (feasibility) [30 minutes]

    Secondary Outcome Measures

    1. Pathologic endoscopic findings in patients suffering from neurogenic dysphagia [30 minutes]

    2. Number of patients with adverse events as a measure of safety and tolerability [1 week]

      safety of transnasal functional endoscopy in diagnostics of neurogenic dysphagia

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients with suspected neurogenic dysphagia, not fulfilling the exclusion criteria
    Exclusion Criteria:
    • Age under 18 years

    • Inability to understand information for participation

    • Refusal of participation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Hospital of Muenster Muenster Germany

    Sponsors and Collaborators

    • University Hospital Muenster

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Dr. Dirk Domagk, Prof. Dr. med. Dirk Domagk, University Hospital Muenster
    ClinicalTrials.gov Identifier:
    NCT01995929
    Other Study ID Numbers:
    • 2012_2013_003
    • TNE_2010
    First Posted:
    Nov 27, 2013
    Last Update Posted:
    Nov 27, 2013
    Last Verified:
    Nov 1, 2013
    Keywords provided by Dr. Dirk Domagk, Prof. Dr. med. Dirk Domagk, University Hospital Muenster
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 27, 2013